Journal Article

Severe Painful Vaso-Occlusive Crises and Mortality in a Contemporary Adult Sickle Cell Anemia Cohort Study

Darbari, Deepika S., Nichols, James, Peters-Lawrence, Marlene, Taylor VI, James G., Kato, Gregory J., Allen, Darlene, Hall, Mary K., Wang, Zhengyuan, Conrey, Anna, Kwak, Minjung, Hildesheim, Mariana, Seamon, Catherine

2013

Overview

Frequent painful vaso-occlusive crises (VOCs) were associated with mortality in the Cooperative Study of Sickle Cell Disease (CSSCD) over twenty years ago. Modern therapies for sickle cell anemia (SCA) like hydroxyurea are believed to have improved overall patient survival. The current study sought to determine the relevance of the association between more frequent VOCs and death and its relative impact upon overall mortality compared to other known risk factors in a contemporary adult SCA cohort. Two hundred sixty four SCA adults were assigned into two groups based on patient reported outcomes for emergency department (ED) visits or hospitalizations for painful VOC treatment during the 12 months prior to evaluation. Higher baseline hematocrit (p = 0.0008), ferritin (p = 0.005), and HDL cholesterol (p = 0.01) were independently associated with 1 or more painful VOCs requiring an ED visit or hospitalization for acute pain. During a median follow-up of 5 years, mortality was higher in the ED visit/hospitalization group (relative risk [RR] 2.68, 95% CI 1.1-6.5, p = 0.03). Higher tricuspid regurgitatant jet velocity (TRV) (RR 2.41, 95% CI 1.5-3.9, p < 0.0001), elevated ferritin (RR 4.00, 95% CI 1.8-9.0, p = 0.001) and lower glomerular filtration rate (RR=2.73, 95% CI 1.6-4.6, p < 0.0001) were also independent risk factors for mortality. Severe painful VOCs remain a marker for SCA disease severity and premature mortality in a modern cohort along with other known risk factors for death including high TRV, high ferritin and lower renal function. The number of patient reported pain crises requiring healthcare utilization is an easily obtained outcome that could help to identify high risk patients for disease modifying therapies. ClinicalTrials.gov NCT00011648 http://clinicaltrials.gov/

• Publisher: Public Library of Science,Public Library of Science (PLoS)
• Subject: Adult / Adults / Analysis / Anemia / Anemia, Sickle Cell - metabolism / Anemia, Sickle Cell - mortality / Anemia, Sickle Cell - physiopathology / Blood cholesterol / Cholesterol / Cholesterol, HDL - metabolism / Cohort analysis / Crises / Emergency medical services / Enrollments / Female / Ferritin / Ferritins - metabolism / Glomerular filtration rate / Health care / Health risks / Health services utilization / Heart / Hematocrit / Hematology / High density lipoprotein / Hospitalization / Humans / Hydroxyurea / Kaplan-Meier Estimate / Logistic Models / Male / Medical research / Medicine / Middle Aged / Mortality / Mutation / Pain / Patient outcomes / Polymerase chain reaction / Proportional Hazards Models / Pulmonary hypertension / Renal function / Risk analysis / Risk Factors / Sickle cell anemia / Sickle cell disease / VOCs / Volatile organic compounds